Sigma Planning Corp’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Buy
17,715
+715
+4% +$4.89K ﹤0.01% 1268
2025
Q4
$33.7K Hold
17,000
﹤0.01% 1286
2025
Q3
$41.8K Hold
17,000
﹤0.01% 1280
2025
Q2
$44.9K Hold
17,000
﹤0.01% 1233
2025
Q1
$51.2K Hold
17,000
﹤0.01% 1183
2024
Q4
$43.5K Hold
17,000
﹤0.01% 1149
2024
Q3
$63.2K Sell
17,000
-795
-4% -$3.68K ﹤0.01% 1183
2024
Q2
$112K Buy
17,795
+4,875
+38% +$32.1K ﹤0.01% 1132
2024
Q1
$69.4K Buy
+12,920
New +$58.5K ﹤0.01% 1189
2023
Q4
Sell
-11,050
Closed -$18.7K 1005
2023
Q3
$18.7K Hold
11,050
﹤0.01% 1180
2023
Q2
$30.7K Hold
11,050
﹤0.01% 1180
2023
Q1
$20.1K Hold
11,050
﹤0.01% 1280
2022
Q4
$56K Buy
11,050
+300
+3% +$1.65K ﹤0.01% 1226
2022
Q3
$53K Hold
10,750
﹤0.01% 1216
2022
Q2
$40K Buy
10,750
+300
+3% +$1.21K ﹤0.01% 1257
2022
Q1
$59K Buy
+10,450
New +$64.1K ﹤0.01% 1333

Other funds holding IBRX